| Bio Medica Laboratories Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | |||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 9.18 | 0.10 | 0.10 | ||
| Reserves | 5.55 | 4.84 | 2.34 | ||
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | ||
| Equity Application Money | 0.00 | 0.00 | 0.00 | ||
| Total Shareholders Funds | 14.73 | 4.94 | 2.44 | ||
| Secured Loans | 11.69 | 9.45 | 8.87 | ||
| Unsecured Loans | 3.32 | 1.04 | 0.73 | ||
| Total Debt | 15.01 | 10.49 | 9.60 | ||
| Other Liabilities | 0.63 | 0.27 | 0.27 | ||
| Total Liabilities | 30.37 | 15.70 | 12.31 | ||
| APPLICATION OF FUNDS : | |||||
| Gross Block | 11.52 | 11.77 | 10.24 | ||
| Less: Accumulated Depreciation | 3.85 | 3.04 | 1.93 | ||
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | ||
| Net Block | 7.67 | 8.73 | 8.31 | ||
| Lease Adjustments | 0.00 | 0.00 | 0.00 | ||
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | ||
| Investments | 0.00 | 0.00 | 0.00 | ||
| Current Assets, Loans & Advances | |||||
| Inventories | 18.14 | 7.37 | 3.90 | ||
| Sundry Debtors | 4.10 | 2.34 | 4.07 | ||
| Cash and Bank Balance | 0.01 | 0.01 | 0.01 | ||
| Loans and Advances | 8.84 | 0.84 | 1.12 | ||
| Total Current Assets | 31.09 | 10.55 | 9.10 | ||
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 4.69 | 2.28 | 4.96 | ||
| Provisions | 4.06 | 1.55 | 0.29 | ||
| Total CL & Provisions | 8.74 | 3.83 | 5.25 | ||
| Net Current Assets | 22.34 | 6.72 | 3.85 | ||
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | ||
| Deferred Tax Assets | 0.22 | 0.13 | 0.03 | ||
| Deferred Tax Liability | 0.00 | 0.00 | 0.00 | ||
| Net Deferred Tax | 0.22 | 0.13 | 0.03 | ||
| Other Assets | 0.13 | 0.12 | 0.13 | ||
| Total Assets | 30.37 | 15.70 | 12.32 | ||
| Contingent Liabilities | 0.05 | 0.05 | 0.05 |